Company Filing History:
Years Active: 2002-2004
Title: Susan Schwendner: Innovator in Combination Therapy
Introduction
Susan Schwendner is a notable inventor based in San Bruno, CA (US). She has made significant contributions to the field of medicine, particularly in the development of combination therapies for treating proliferative disorders. With a total of 2 patents, her work has the potential to impact cancer treatment significantly.
Latest Patents
Susan's latest patents include innovative approaches to combination therapy using pentafluorobenzenesulfonamides. The first patent focuses on the use of pentafluorobenzenesulfonamide in conjunction with antineoplastic agents such as gemcitabine or paclitaxel. The second patent also explores combination therapies that utilize pentafluorobenzenesulfonamides alongside antineoplastic platinum coordination complexes like cisplatin. These patents highlight her commitment to advancing therapeutic options for patients with proliferative disorders.
Career Highlights
Throughout her career, Susan has worked at Tularik Limited, where she has been instrumental in research and development. Her innovative spirit and dedication to improving patient outcomes have made her a respected figure in her field.
Collaborations
Susan has collaborated with talented individuals such as Pieter Timmermans and Jacqueline Walling. These partnerships have fostered a creative environment that encourages the development of groundbreaking therapies.
Conclusion
In summary, Susan Schwendner is a pioneering inventor whose work in combination therapies is paving the way for new treatment options in the medical field. Her contributions are vital to the ongoing fight against proliferative disorders.